Latest Breaking News On - Ketamine endgame - Page 1 : vimarsana.com

ENGLEWOOD CLIFFS, NJ, April 24, 2023 (GLOBE NEWSWIRE) Silo Pharma, Inc.  (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical.

New yorkUnited statesJames kuoDrug development conferenceNew york timesSilo pharma incVice presidentPsychedelic therapeuticsHilton san francisco airport bayfrontKetamine endgameSilo pharmaAnnual psychedelic therapeuticsDrug developmentLooking statementsNasdaq siloSilo pharma